[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BiopharmIQ by Amp [@BiopharmIQ](/creator/twitter/BiopharmIQ) on x 25.6K followers Created: 2025-07-15 23:06:29 UTC $LRMR ✔️ Nomlabofusp (CTI-1601) / Friedreich’s Ataxia / Phase X » Generally well tolerated » Dose dependent increases of frataxin levels in tissues tested (skin and buccal cells) » FXN levels increased to XX% to XX% of the average of the healthy volunteers after OD x XX days dosing Prior results 📸 👇 7/7  XXXXX engagements  **Related Topics** [$lrmr](/topic/$lrmr) [Post Link](https://x.com/BiopharmIQ/status/1945258697317605760)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BiopharmIQ by Amp @BiopharmIQ on x 25.6K followers
Created: 2025-07-15 23:06:29 UTC
$LRMR ✔️ Nomlabofusp (CTI-1601) / Friedreich’s Ataxia / Phase X
» Generally well tolerated
» Dose dependent increases of frataxin levels in tissues tested (skin and buccal cells)
» FXN levels increased to XX% to XX% of the average of the healthy volunteers after OD x XX days dosing
Prior results 📸 👇
7/7
XXXXX engagements
Related Topics $lrmr
/post/tweet::1945258697317605760